Sodium Iodide I-131Therapeutic (MALLINCKRODT NUCLEAR MEDICINE LLC)


Welcome to the PulseAid listing for the Sodium Iodide I-131 drug offered from MALLINCKRODT NUCLEAR MEDICINE LLC. This Radioactive Therapeutic Agent [EPC],Radiopharmaceutical Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: MALLINCKRODT NUCLEAR MEDICINE LLC
NON-PROPRIETARY NAME: sodium iodide, i-131
SUBSTANCE NAME: SODIUM IODIDE I-131
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Radioactive Therapeutic Agent [EPC],Radiopharmaceutical Activity [MoA]
ROUTE: ORAL
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-10-27
END MARKETING DATE: 0000-00-00


Sodium Iodide I-131 Therapeutic HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSodium Iodide I-131 Therapeutic from MALLINCKRODT NUCLEAR MEDICINE LLC
LABELER NAME: MALLINCKRODT NUCLEAR MEDICINE LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mCi/mL)
START MARKETING DATE: 2015-10-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69945-450_d70c5437-3152-4393-830b-53c61acfc87c
PRODUCT NDC: 69945-450
APPLICATION NUMBER: NDA016515

Other SODIUM IODIDE I-131 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnazaoHealth CorporationI 131 Mini
International Isotopes IncSodium Iodide I-131
Jubilant DraxImage Inc.Sodium Iodide I 131 Diagnostic
MALLINCKRODT NUCLEAR MEDICINE LLCSodium Iodide I-131